BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin Y, Ma C, Bezabeh T, Wang Z, Liang J, Huang Y, Zhao J, Liu X, Ye W, Tang W, Ouyang T, Wu R. 1 H NMR-based metabolomics reveal overlapping discriminatory metabolites and metabolic pathway disturbances between colorectal tumor tissues and fecal samples. Int J Cancer. 2019;145:1679-1689. [PMID: 30720869 DOI: 10.1002/ijc.32190] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Nannini G, Meoni G, Amedei A, Tenori L. Metabolomics profile in gastrointestinal cancers: Update and future perspectives. World J Gastroenterol 2020; 26(20): 2514-2532 [PMID: 32523308 DOI: 10.3748/wjg.v26.i20.2514] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
2 Liang JH, Lin Y, Ouyang T, Tang W, Huang Y, Ye W, Zhao JY, Wang ZN, Ma CC. Nuclear magnetic resonance-based metabolomics and metabolic pathway networks from patient-matched esophageal carcinoma, adjacent noncancerous tissues and urine. World J Gastroenterol 2019; 25(25): 3218-3230 [PMID: 31333313 DOI: 10.3748/wjg.v25.i25.3218] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Song M, Chan AT, Sun J. Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer.Gastroenterology. 2020;158:322-340. [PMID: 31586566 DOI: 10.1053/j.gastro.2019.06.048] [Cited by in Crossref: 92] [Cited by in F6Publishing: 86] [Article Influence: 46.0] [Reference Citation Analysis]
4 Yuan F, Kim S, Yin X, Zhang X, Kato I. Integrating Two-Dimensional Gas and Liquid Chromatography-Mass Spectrometry for Untargeted Colorectal Cancer Metabolomics: A Proof-of-Principle Study. Metabolites 2020;10:E343. [PMID: 32854360 DOI: 10.3390/metabo10090343] [Reference Citation Analysis]
5 Erben V, Poschet G, Schrotz-King P, Brenner H. Comparing Metabolomics Profiles in Various Types of Liquid Biopsies among Screening Participants with and without Advanced Colorectal Neoplasms. Diagnostics (Basel) 2021;11:561. [PMID: 33804777 DOI: 10.3390/diagnostics11030561] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Peng Y, Nie Y, Yu J, Wong CC. Microbial Metabolites in Colorectal Cancer: Basic and Clinical Implications. Metabolites 2021;11:159. [PMID: 33802045 DOI: 10.3390/metabo11030159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Olovo CV, Huang X, Zheng X, Xu M. Faecal microbial biomarkers in early diagnosis of colorectal cancer. J Cell Mol Med 2021. [PMID: 34750964 DOI: 10.1111/jcmm.17010] [Reference Citation Analysis]
8 Fang LJ, Lin XC, Huang D, Pan TT, Yan XM, Hu WG, Zhu H, Xu Z, Zhu XZ, Lu HJ, Chen GP, Huang KY. 1H NMR-based metabolomics analyses in children with Helicobacter pylori infection and the alteration of serum metabolites after treatment. Microb Pathog 2020;147:104292. [PMID: 32505653 DOI: 10.1016/j.micpath.2020.104292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Nannini G, Meoni G, Tenori L, Ringressi MN, Taddei A, Niccolai E, Baldi S, Russo E, Luchinat C, Amedei A. Fecal metabolomic profiles: A comparative study of patients with colorectal cancer vs adenomatous polyps. World J Gastroenterol 2021; 27(38): 6430-6441 [PMID: 34720532 DOI: 10.3748/wjg.v27.i38.6430] [Reference Citation Analysis]
10 Reinsalu L, Puurand M, Chekulayev V, Miller S, Shevchuk I, Tepp K, Rebane-Klemm E, Timohhina N, Terasmaa A, Kaambre T. Energy Metabolic Plasticity of Colorectal Cancer Cells as a Determinant of Tumor Growth and Metastasis. Front Oncol 2021;11:698951. [PMID: 34381722 DOI: 10.3389/fonc.2021.698951] [Reference Citation Analysis]
11 Veziant J, Villéger R, Barnich N, Bonnet M. Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer. Cancers (Basel) 2021;13:2215. [PMID: 34063108 DOI: 10.3390/cancers13092215] [Reference Citation Analysis]
12 Di Giovanni N, Meuwis M, Louis E, Focant J. Specificity of metabolic colorectal cancer biomarkers in serum through effect size. Metabolomics 2020;16. [DOI: 10.1007/s11306-020-01707-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sun R, Gu J, Chang X, Liu F, Liang Y, Yang X, Liang L, Tang D. Metabonomics study on orthotopic transplantion mice model of colon cancer treated with Astragalus membranaceus-Curcuma wenyujin in different proportions via UPLC-Q-TOF/MS. J Pharm Biomed Anal 2021;193:113708. [PMID: 33129117 DOI: 10.1016/j.jpba.2020.113708] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Nandy D, Craig SJC, Cai J, Tian Y, Paul IM, Savage JS, Marini ME, Hohman EE, Reimherr ML, Patterson AD, Makova KD, Chiaromonte F. Metabolomic profiling of stool of two-year old children from the INSIGHT study reveals links between butyrate and child weight outcomes. Pediatr Obes 2021;:e12833. [PMID: 34327846 DOI: 10.1111/ijpo.12833] [Reference Citation Analysis]
15 Ye W, Lin Y, Bezabeh T, Ma C, Liang J, Zhao J, Ouyang T, Tang W, Wu R. 1 H NMR-based metabolomics of paired esophageal tumor tissues and serum samples identifies specific serum biomarkers for esophageal cancer. NMR Biomed 2021;34:e4505. [PMID: 33783927 DOI: 10.1002/nbm.4505] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Tang Z, Xu Z, Zhu X, Zhang J. New insights into molecules and pathways of cancer metabolism and therapeutic implications. Cancer Commun (Lond) 2021;41:16-36. [PMID: 33174400 DOI: 10.1002/cac2.12112] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]